My mother also had osteoporosis.

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...

GLP-1 receptor agonist use was linked to a significantly higher risk for osteoporosis, gout, and osteomalacia over 5 years.

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's ...

Please provide your email address to receive an email when new articles are posted on . “There is abundant evidence that men are not adequately screened for osteoporosis, and those with osteoporosis ...

Oral bisphosphonates are common first line treatments for osteoporosis. However, approximately half of patients who begin osteoporosis treatment do not follow their prescribed treatment and/or ...

Figure 1 shows annual osteoporosis prevalence and treatment estimates from MEPS years 1999 to 2005 among the sample of patients ages 50 years and older who self-reported osteoporosis. Self-report of ...

Purpose. Trends in the use of different treatments for osteoporosis among the civilian, ambulatory U.S. population are described. Methods. Data from the Medical Expenditure Panel Survey (MEPS) were ...